Schedule change for bisacodyl 5 mg tablets and 10 mg suppositories

January 24, 2014

Effective January 21, 2014:

  • Bisacodyl - when sold in concentrations of 5 mg or less per oral dosage unit or 10 mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50 mg of bisacodyl -  Unscheduled status (from Schedule III)
     
  • Bisacodyl and its salts [except when sold in concentrations of 5 mg or less per oral dosage unit or 10 mg or less per rectal dosage unit/suppository in package sizes containing no more than 50 mg of bisacodyl]  - remains in Schedule III

 


← Previous ArticleNext Article →